| PD-1 blockade in tumors with mismatch-repair deficiency DT Le, JN Uram, H Wang, BR Bartlett, H Kemberling, AD Eyring, ... New England Journal of Medicine 372 (26), 2509-2520, 2015 | 9466 | 2015 |
| Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade DT Le, JN Durham, KN Smith, H Wang, BR Bartlett, LK Aulakh, S Lu, ... Science 357 (6349), 409-413, 2017 | 6006 | 2017 |
| Detection of Circulating Tumor DNA in Early-and Late-Stage Human Malignancies C Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ... Science translational medicine 6 (224), 224ra24-224ra24, 2014 | 4688 | 2014 |
| AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer ES Antonarakis, C Lu, H Wang, B Luber, M Nakazawa, JC Roeser, ... New England Journal of Medicine 371 (11), 1028-1038, 2014 | 2815 | 2014 |
| Neoadjuvant PD-1 blockade in resectable lung cancer PM Forde, JE Chaft, KN Smith, V Anagnostou, TR Cottrell, MD Hellmann, ... New England Journal of Medicine 378 (21), 1976-1986, 2018 | 1902 | 2018 |
| The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints NJ Llosa, M Cruise, A Tam, EC Wicks, EM Hechenbleikner, JM Taube, ... Cancer discovery 5 (1), 43-51, 2015 | 1473 | 2015 |
| Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging M Law, S Yang, H Wang, JS Babb, G Johnson, S Cha, EA Knopp, ... American Journal of Neuroradiology 24 (10), 1989-1998, 2003 | 1425 | 2003 |
| Evidence for a role of the PD-1: PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma S Lyford-Pike, S Peng, GD Young, JM Taube, WH Westra, B Akpeng, ... Cancer research 73 (6), 1733-1741, 2013 | 841 | 2013 |
| Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria CM Dejea, P Fathi, JM Craig, A Boleij, R Taddese, AL Geis, X Wu, ... Science 359 (6375), 592-597, 2018 | 835 | 2018 |
| Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ... JAMA oncology, 2020 | 816 | 2020 |
| Androgen receptor splice variant 7 and efficacy of taxane chemotherapy in patients with metastatic castration-resistant prostate cancer ES Antonarakis, C Lu, B Luber, H Wang, Y Chen, M Nakazawa, R Nadal, ... JAMA oncology 1 (5), 582-591, 2015 | 677 | 2015 |
| Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival AC Berger, J Farma, WJ Scott, G Freedman, L Weiner, JD Cheng, H Wang, ... Journal of clinical oncology 23 (19), 4330-4337, 2005 | 562 | 2005 |
| Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells K Sadtler, K Estrellas, BW Allen, MT Wolf, H Fan, AJ Tam, CH Patel, ... Science 352 (6283), 366-370, 2016 | 532 | 2016 |
| Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta-analysis S Lu, JE Stein, DL Rimm, DW Wang, JM Bell, DB Johnson, JA Sosman, ... JAMA oncology, 2019 | 515 | 2019 |
| Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response R Mandal, RM Samstein, KW Lee, JJ Havel, H Wang, C Krishna, ... Science 364 (6439), 485-491, 2019 | 440 | 2019 |
| Clinical significance of androgen receptor splice variant-7 mRNA detection in circulating tumor cells of men with metastatic castration-resistant prostate cancer treated with … ES Antonarakis, C Lu, B Luber, H Wang, Y Chen, Y Zhu, JL Silberstein, ... Journal of Clinical Oncology 35 (19), 2149, 2017 | 434 | 2017 |
| PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus, and overall survival EJ Lipson, JG Vincent, M Loyo, LT Kagohara, BS Luber, H Wang, H Xu, ... Cancer immunology research 1 (1), 54-63, 2013 | 426 | 2013 |
| Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions BR Balsara, J Pei, Y Mitsuuchi, R Page, A Klein-Szanto, H Wang, ... Carcinogenesis 25 (11), 2053-2059, 2004 | 368 | 2004 |
| UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan LE Carlini, NJ Meropol, J Bever, ML Andria, T Hill, P Gold, A Rogatko, ... Clinical cancer research 11 (3), 1226-1236, 2005 | 347 | 2005 |
| Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection NE Joseph, ER Sigurdson, AL Hanlon, H Wang, RJ Mayer, JS MacDonald, ... Annals of surgical oncology 10 (3), 213-218, 2003 | 309 | 2003 |
Emmanuel S. Antonarakis, M.D.Clark Endowed Professor of Medicine, University of MinnesotaE-mail confirmado em umn.edu
